| Stage | HUN | % of rev | SOLS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.7B | 100.00% | $1.1B | 100.00% | HUN ×1.45 |
| Gross profit | $245M | 14.73% | $370M | 32.23% | SOLS +17.5pp |
| Operating income | $37M | 2.22% | $197M | 17.16% | SOLS +14.9pp |
| Pre-tax income | $26M | 1.56% | $176M | 15.33% | SOLS +13.8pp |
| Net income | $7M | 0.42% | $134M | 11.67% | SOLS +11.3pp |
| Stage | HUN | SOLS | Gap · A − B |
|---|---|---|---|
| Revenue | $1.7B100.00% | $1.1B100.00% | HUN ×1.45 |
| Gross profit | 14.73%$245M | 32.23%$370M | SOLS +17.5pp |
| Operating income | 2.22%$37M | 17.16%$197M | SOLS +14.9pp |
| Pre-tax income | 1.56%$26M | 15.33%$176M | SOLS +13.8pp |
| Net income |
| 0.42%$7M |
| 11.67%$134M |
| SOLS +11.3pp |
No shared counterparties.